VIE/VLA (VIE/VLA)

Vienna Stock Exchange: VIE/VLA · EUR

€2.48

-0.08 (-3.2%)· Recorded snapshot

Market cap	470.1M
Revenue (ttm)	142.9M
Net income (ttm)	-157.7M
EPS (ttm)	-€0.88
Volume	962
Beta	1.26

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 142.9M
Net income (ttm): -157.7M
EPS (ttm): -€0.88
Market cap: 470.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 14.3P50 18.7P75 25.4

Trailing P/En/a

P25 20.4P50 26.7P75 39.7

ROE-117.8

P25 4.8P50 10.6P75 20.1

ROIC-65.5

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/VLA indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

EUR

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	France
Country code	AT
Earnings date	2026-11-12
Employees	620
Employees change	-39
Employees growth	-5.47%
Enterprise value	EUR 558.8M
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1998
Industry	Biotechnology
Is primary listing	No
ISIN number	FR0004056851
Last earnings date	2026-08-13
Last refreshed	2026-10-29
Market cap	EUR 470.1M
Next earnings date	2026-11-12
Price	EUR 2.48
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	vie/VLA
Website	https://valneva.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-35.68%
EV/Sales	4.02x
FCF / EV yield	-10.11%
FCF yield	-11.95%
P/B ratio	5.98x
P/S ratio	3.4x
Price / tangible book value	8.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-80.38%
EBITDA margin	-69.07%
Gross margin	-41.73%
Operating margin	-80.38%
Pretax margin	-110.24%
Profit margin	-110.29%
Profit per employee	EUR -254,274
Revenue per employee	EUR 230,545
ROA	-16.68%
ROA (5Y)	-7.04%
ROCE	-40.32%
ROE	-117.85%
ROE (5Y)	-55.79%
ROIC	-65.51%
SBC / revenue	6.15%
Tax / revenue	0.06%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth	-27.19%
Revenue growth (Q)	-27.71%
Revenue growth (QoQ)	13.05%
Revenue growth 10Y	4.11%
Revenue growth 3Y	-30.49%
Revenue growth 5Y	5.39%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -2.3M
Depreciation and amortization	EUR 16.2M
EBIT	EUR -114.9M
EBITDA	EUR -98.7M
EPS	EUR -0.88
Financing cash flow	EUR 14.6M
Free cash flow	EUR -58M
Free cash flow minus SBC	EUR -66.8M
Gross profit	EUR -59.7M
Income taxes	EUR 80,000
Investing cash flow	EUR 564,000
Net borrowing	EUR -432,000
Net cash flow	EUR -39.8M
Net income	EUR -157.7M
Operating cash flow minus SBC	EUR -64.5M
Operating income	EUR -114.9M
Revenue	EUR 142.9M
Stock-based compensation	EUR 8.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1.73
Book value per share	EUR 0.43
Debt / equity	2.59
Interest coverage	-2.83
Long-term assets	EUR 165.4M
Long-term liabilities	EUR 203.8M
Net cash (debt)	EUR -88.7M
Net cash / market cap	-18.27%
Net debt / equity	1.09
Piotroski F-Score	1
Property, plant and equipment	EUR 128.5M
Shareholders' equity	EUR 81.1M
Tangible book value	EUR 60.2M
Tangible book value per share	EUR 0.32
Total assets	EUR 388.3M
Total cash	EUR 121.5M
Total debt	EUR 210.2M
Total liabilities	EUR 307.2M
WACC	12.4%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.33
Current assets	EUR 222.9M
Current liabilities	EUR 103.3M
Current ratio	2.16
Inventory turnover	3.69
Net working capital	EUR 19.2M
Quick ratio	1.33
Working capital	EUR 119.5M
Working capital turnover	1.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-13.1%
Shareholder yield	-13.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	0.24%
10Y return CAGR	0.02%
10Y total return	0.24%
150-day SMA	EUR 2.52
1D price change	-3.17%
1M price change	-8.02%
1M total return	-8.02%
1W price change	1.43%
1W total return	1.43%
1Y price change	-34.23%
1Y return CAGR	-34.24%
1Y total return	-34.23%
20-day SMA	EUR 2.55
200-day SMA	EUR 2.96
3M price change	16.02%
3M total return	16.02%
3Y price change	-51.68%
3Y return CAGR	-21.53%
3Y total return	-51.68%
50-day SMA	EUR 2.73
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 5.12
52-week high date	2026-02-25
52-week low	EUR 2.05
52-week low date	2026-07-24
5Y price change	-86.96%
5Y return CAGR	-33.47%
5Y total return	-86.96%
6M price change	7.08%
6M total return	7.08%
All-time high	EUR 29.60
All-time high date	2021-11-30
All-time low	EUR 1.75
All-time low date	2024-12-17
Average true range (ATR)	EUR 0.11
Average volume	521.1
Beta (5Y)	1.26
Change from 52-week high	-51.61%
Change from 52-week low	20.85%
Change from all-time high	-91.36%
Change from all-time low	46.31%
Change from open	-1%
Day's gap	-2.19%
Dollar volume	EUR 2,381
High price	EUR 2.57
Low price	EUR 2.48
Monthly RSI	43.22
Open price	EUR 2.50
Position in 52-week range	0%
Previous close	EUR 2.56
Price vs 150-day SMA	1.47%
Price vs 20-day SMA	0.31%
Price vs 200-day SMA	-13.56%
Price vs 50-day SMA	-6.37%
Relative volume	1.99
RSI	44.96
Sharpe ratio	-0.24
Sharpe ratio (3Y)	-0.04
Sharpe ratio (5Y)	-0.17
Sortino ratio	-0.26
Sortino ratio (3Y)	0.02
Sortino ratio (5Y)	-0.17
Volume	962
Weekly RSI	43.89
YTD price change	-31.88%
YTD total return	-31.88%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	171.4M
Shares change (QoQ)	2.92%
Shares change (YoY)	13.1%
Shares held by insiders	1.31%
Shares held by institutions	24.72%

Deeper analysis on VIE/VLA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/VLA report

Is a complete VIE/VLA research report available?

No complete published report is available for vie/VLA (VIE/VLA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/VLA (VIE/VLA)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/VLA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/VLA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/VLA

Frequently asked questions